2nd wave of Covid-19 in India could last up to 100 days, peak in April: Report says vaccination more effective

India is in the midst of a second wave of the Covid-19 pandemic. Considering the length from the current degree of day by day new instances to the peak India noticed last yr, the nation is anticipated to attain the excessive in the second half of April. The second wave, which could last till the tip of May, could see an addition of 25 lakh instances if tendencies till March 23 are taken into consideration.

These projections are half of findings of a State Bank of India (SBI) analysis report titled ‘The second wave of infections: The beginning of the end’ by Chief Economic Advisor Soumya Kanti Ghosh.

In the report, Ghosh assessed that the length of the second Covi-19 wave may last up to 100 days ranging from Feb 15, whereas he added that vaccination is a more effective manner than lockdown to beat the pandemic.

“Though global Covid-19 experience shows the second wave much higher in intensity than the first wave, presence of vaccine makes the difference currently. But India will be able to manage the situation better,” the report mentioned.

India reported 53,476 instances in a day on March 25, the very best since November 6, 2020 — Maharashtra and Punjab being the worst-affected states.

(Table supply:SBI)

The day by day spike in coronavirus instances in the course of the peak in the second wave could be a lot increased than last yr, the report warns because it cites France which noticed the peak of day by day instances round 11.5 occasions more than the primary wave.

The solely silver lining this time, in accordance to the report, is the provision of vaccines towards Covid-19.

(Table supply:SBI)


The report argued that if one considers the quantity of days taken to attain the present degree from the bottom degree of day by day new instances witnessed on February 21, the time it took for the second Covid-19 wave to hit India is comparable to what occurred in the primary wave.

“However, the difference lies in the speed of spread of infection in states like Gujarat, MP, Maharashtra, Punjab and Chhattisgarh, where the cases have increased at a much faster pace during the current second wave,” the report acknowledged.

Considering the quantity of days from the present degree of day by day new instances to the peak degree in the course of the first wave, India may attain the peak in the second half of April, the report says and provides that your entire length of the second wave may last up to 100 days counted (from Feb 15).


A district-wise evaluation in the report revealed that instances have once more began rising in the highest 15 districts of India, principally city, whereas the unfold in rural districts is nearly secure.

It says that instances are largely localised and concentrated and whereas Rajasthan, Gujarat, Kerala, Uttarakhand, Haryana have vaccinated more than 20 per cent of their aged inhabitants, different states with a better aged inhabitants (>60 years) like Punjab, Tamil Nadu, Andhra Pradesh, Maharashtra and West Bengal have vaccinated a lesser proportion.

The report factors out that Kerala had the utmost quantity of worst-affected districts in January 2021. However, all districts in this top-10 checklist are actually rural districts of Maharashtra.

(Table supply:SBI)


Recommending a robust push to the vaccination programme, the report says, “If the daily vaccine inoculation increases to 40-45 lakh from the current maximum level of 34 lakh, then we can vaccinate our population above 45 years in four months from now.”

The SBI report additionally proposes restrictions to forestall the unfold of Covid-19. “Air travel has slowly inched towards the level it was at…However, a plethora of new variants emerging still make a case for being wary about the overall recovery in air travel,” the report famous.

The SBI stories additionally voiced opposition to lockdown. “Localised lockdowns have not resulted in controlling the spread of infection as visible in states like Maharashtra and Punjab.”

Daily new instances and loss of life charge proceed to rise even after lockdown or restrictions are imposed. (Table supply:SBI)

Based on analyses of information, the report mentioned the instances and loss of life charge each appear to be unaffected with lockdown or restrictions imposed, as is clearly seen in the case of many states and even the districts, aside from Amravati present that day by day new instances and loss of life charge each proceed to rise even after lockdown or restrictions are imposed.”

Building a case towards the re-imposition of extreme restrictions, Ghosh mentioned in the report, “The second wave occurred only after restrictions imposed in the wake of the first wave were relaxed. If highly effective NPIs (non-pharmaceutical interventions) are put in place early in the epidemic, and these result in a smaller epidemic, then a large proportion of the population will remain susceptible to the renewed spread of the virus once interventions are relaxed.”

The report added that in phrases of ‘injection-to-infection ratio’, Israel, UK and Chile had been doing higher than India. However, the tempo of vaccination/hundred inhabitants in India was a lot increased in contrast to different nations, it famous.

The examine additionally analysed the present charge, the required charge and the constraints of vaccine manufacturing. Ghosh contended that going by the well being infrastructure, India has the capability to improve the day by day doses to round 1 crore per day from the present 34 lakh.

The day by day manufacturing capability of Covishield and Covaxin is round 52 lakh per day and together with the export of vaccines, the report creates a stability between the provision and quantum of jabs per day.

“If more people are willing to take vaccines and with the current production capacity, the daily vaccine inoculation can be increased to 40-45 lakh from the current maximum level of 34 lakh. Then people above 45 years of age can be vaccinated in four months and the entire population in a year and nine months.”

ALSO READ | Delhi’s Covid-19 journey in past one year

ALSO READ | Pfizer, BioNTech launch Covid-19 vaccine trial in kids under 12

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.